ARYA Sciences Acquisition Corp II (47) | Uncategorized (8)

Recent Contracts

Amendment No. 1 to Business Combination Agreement, dated as of October 2, 2020, by and between ARYA Sciences Acquisition Corp II and Cerevel Therapeutics, Inc (Filed With SEC on March 24, 2021)
Description of the Registrants securities registered pursuant to Section 12 of the Securities and Exchange Act of 1934, as amended (Filed With SEC on March 24, 2021)
Offer Letter, dated August 18, 2019, by and between Cerevel Therapeutics, LLC and Mark Bodenrader (Filed With SEC on November 16, 2020)
Amendment No. 1 to Business Combination Agreement, dated October 2, 2020 (Filed With SEC on October 5, 2020)
Letter Agreement among the Company, the Sponsor and the Companys officers and directors (Filed With SEC on June 9, 2020)
Specimen Unit Certificate (Filed With SEC on May 29, 2020)
Form of Indemnity Agreement (Filed With SEC on May 29, 2020)
Form of Letter Agreement between the Registrant, the Sponsor and each director and officer of the Registrant (Filed With SEC on May 29, 2020)